To compare this unexpected change in YAP expression with another model of human breast cancer with KRAS mutations, we first examined tumors similarly generated in female NRG mice 8 weeks after being injected with KRASG12D-transduced MCF10A cells [23]. This evidence concerns the gene KRAS and breast cancer.